ADMA Biologics ADMA Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's total current liabilities?
- ADMA Biologics (ADMA) reported total current liabilities of $73.54M in Q1 2026.
- How has ADMA Biologics's total current liabilities changed year-over-year?
- ADMA Biologics's total current liabilities increased by 37.5% year-over-year, from $53.5M to $73.54M.
- What is the long-term trend for ADMA Biologics's total current liabilities?
- Over 5 years (2020 to 2025), ADMA Biologics's total current liabilities has grown at a 28.4% compound annual growth rate (CAGR), from $19.95M to $69.54M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.